RxDoctor Payments Data

Patrick Rood

Physician Assistant · Amherst, NYNPI 1679681985

Payments from drug & device makers

$14,145in general payments, 2019–2025

Across 856 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$1K
  • MDD US Operations, LLC$1K
  • Novartis$1K
  • AbbVie$1K
  • Amgen$1K
  • Teva Pharmaceuticals USA, Inc.$801
  • plus $7K from 47 others

What the payments were for

  • Consulting fees$1501%
  • Food & beverage$13,80598%
  • Education$1901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,145 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$30,545
Medicare patients
246
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Radicava OrsEdaravone20$291,194
Gamunex-CImmune Globul G/Gly/Iga Avg 4671$249,107
OctagamImmun Globg(Igg)/Malt/Iga Ov5022$209,326
GilenyaFingolimod Hcl17$163,325
Avonex Pen (4 Pack)Interferon Beta-1a18$144,015
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5013$122,970
FingolimodFingolimod Hcl19$67,120
Dimethyl Fumarate11$47,631
Glatiramer Acetate13$39,938
Rasagiline Mesylate72$15,802
Gabapentin302$6,557
Carbidopa-LevodopaCarbidopa/Levodopa151$6,010
Pregabalin125$4,508
Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone11$4,496
Pyridostigmine Bromide71$4,122

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Grifols USA, LLCGamunex-C$21$249,10771 claims
PfizerOctagam$297$209,32622 claims
NovartisGilenya$1,096$163,32517 claims
Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid$20$122,97013 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide, Mycophenolate Mofetil$354$6,09188 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Amherst

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →